VistaGen Therapeutics, Inc.

NasdaqCM:VTGN Stock Report

Mkt Cap: US$39.7m

VistaGen Therapeutics Future Growth

How is VistaGen Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


66.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqCM:VTGN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202576-28N/AN/A2
3/31/20241-65N/AN/A1
3/31/20230-65N/AN/A2
9/30/20220-65-60-60N/A
6/30/20221-60-55-55N/A
3/31/20221-49-45-45N/A
12/31/20212-62-35-35N/A
9/30/20211-56-28-28N/A
6/30/20211-47-16-15N/A
3/31/20211-42-12-12N/A
12/31/20201-16-10-9N/A
9/30/20200-17-9-9N/A
6/30/2020N/A-19-14-14N/A
3/31/2020N/A-22-16-16N/A
12/31/2019N/A-24-17-17N/A
9/30/2019N/A-26-16-16N/A
6/30/2019N/A-28-16-16N/A
3/31/2019N/A-26-15-15N/A
12/31/2018N/A-24-14-14N/A
9/30/2018N/A-20-12-12N/A
6/30/2018N/A-18-10-10N/A
3/31/2018N/A-16-9-9N/A
12/31/2017N/A-14-8-8N/A
9/30/20171-13-8-7N/A
6/30/20171-12-8-8N/A
3/31/20171-12-8-7N/A
12/31/20161-18-7-7N/A
9/30/2016N/A-19-6-6N/A
6/30/2016N/A-24N/A-6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VTGN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: VTGN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: VTGN is expected to become profitable in the next 3 years.

Revenue vs Market: VTGN's revenue (71.2% per year) is forecast to grow faster than the US market (6.9% per year).

High Growth Revenue: VTGN's revenue (71.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if VTGN's Return on Equity is forecast to be high in 3 years time


Discover growth companies